Chen Xi Huang Wong

China QinBa Pharmaceuticals, Inc. manufactures pharmaceutical products in the form of capsules, oral solutions, tablets, granules, syrups, medicinal teas, tincture and solutions for injection that are either small volume parenteral solutions that are freeze dried powders or large volume parenteral solutions. It manufactures pharmaceutical products for various diseases and conditions, including body fluid loss, hypophosphataemia and viral pneumonia. China QinBa Pharmaceuticals was incorporated on May 29, 2008 and is headquartered in Xi’an City, China.

Headquartered in New York City, New York Global Securities, Inc. is a broker/dealer. They offer a full array of investment services. The firm has two core areas of focus. One is research and investment in small and medium-sized enterprises in China and the other is the tech value chain throughout Asia and the US. They are a member of the NASD and the SIPC.